Cited by 100Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchGenomic variations and chromosomal abnormalities

Rare autosomal copy number variations in early-onset familial Alzheimer’s disease

Open access
Hooli, B V, Kovacs-Vajna, Z M, Mullin, K, Blumenthal, M A, Mattheisen, M, Zhang, C, Lange, C, Mohapatra, G +2 more·2014·Molecular Psychiatry

Abstract

Over 200 rare and fully penetrant pathogenic mutations in amyloid precursor protein (APP), presenilin 1 and 2 (PSEN1 and PSEN2) cause a subset of early-onset familial Alzheimer's disease (EO-FAD). Of these, 21 cases of EO-FAD families carrying unique APP locus duplications remain the only pathogenic copy number variations (CNVs) identified to date in Alzheimer's disease (AD). Using high-density DNA microarrays, we performed a comprehensive genome-wide analysis for the presence of rare CNVs in 261 EO-FAD and early/mixed-onset pedigrees. Our analysis revealed 10 novel private CNVs in 10 EO-FAD families overlapping a set of genes that includes: A2BP1, ABAT, CDH2, CRMP1, DMRT1, EPHA5, EPHA6, ERMP1, EVC, EVC2, FLJ35024 and VLDLR. In addition, CNVs encompassing two known frontotemporal dementia genes, CHMP2B and MAPT were found. To our knowledge, this is the first study reporting rare gene-rich CNVs in EO-FAD and early/mixed-onset AD that are likely to underlie pathogenicity in familial AD and perhaps related dementias.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2013.77

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Rare autosomal CNVs in genes besides APP have been implicated in EOAD.

    “Rare autosomal CNVs in genes besides APP have been implicated in EOAD [252]”

    From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [252]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Townson JR, Barcellos LF, Nibbs RJ. Gene copy number regulates the production of the human chemokine CCL3-L1. Eur J Immunol 2002; 32: 3016-3026.
  2. Mohapatra G, Moore DH, Kim DH, Grewal L, Hyun WC, Waldman FM et al. Analyses of brain tumor cell lines confirm a simple model of relationships among fluor- escence in situ hybridization, DNA index, and comparative genomic hybridization. Genes Chromosomes Cancer 1997; 20: 311-319.

Cited by

Sorted by citations

Authors
Hooli, B. V., Kovacs-Vajna, Z. M., Mullin, K., Blumenthal, M. A., Mattheisen, M., Zhang, C., Lange, C., Mohapatra, G., Bertram, L., & Tanzi, R. E.
Affiliations
  • Massachusetts General Hospital (US)
  • University of Brescia (IT)
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
  • Max Planck Society (DE)
Corresponding author
Tanzi, R E
Venue
Molecular Psychiatry
Published
2013-06-11
Volume
19
Issue
6
Pages
676-681
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2082651728
Cited by
100
References
72
Citations by year
2026: 2 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 12 · 2021: 15 · 2020: 4 · 2019: 9 · 2018: 14 · 2017: 6 · 2016: 10 · 2015: 8 · 2014: 6 · 2013: 1
FWCI
5.80
Type
journal article
Language
en
Open access
Locations
  • Molecular Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Max Planck Digital Library (submittedVersion, other-oa)
  • Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
Funders
  • Lundbeckfonden (R155-2014-1724)
  • National Institute on Aging (U24AG021886)
  • National Institute of Mental Health
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
early-onset familial Alzheimer's disease, copy number variation, amyloid precursor protein, presenilin 1, presenilin 2, A2BP1, 4-aminobutyrate aminotransferase, N-cadherin, CRMP1, DMRT1, EphA5, EPHA6, EVC, EVC2, VLDLR, CHMP2B, MAPT, frontotemporal dementia, early-onset Alzheimer's disease
MeSH terms
Adult, Aged, Alzheimer Disease, Family, Female, Humans, Male, Middle Aged, Pedigree, Cohort Studies, Age of Onset, Oligonucleotide Array Sequence Analysis, DNA Copy Number Variations

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review